Exploring the Effect of Combined Chinese and Western Treatment on Home Medical Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-01

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

combine antihypertensive drugs and acupuncture to isolated systolic hypertension elderly patients at home

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Acupuncture on Patients With Mild Hypertension

NCT01701726

Essential Hypertension

COMPLETED PHASE3

Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial

NCT04381520

Primary Hypertension

UNKNOWN NA

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

NCT04788563

Primary Hypertension

COMPLETED NA

Acupuncture in Patients With Stable Angina Pectoris

NCT01686230

Angina, Stable

COMPLETED NA

Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence

NCT03450902

Urinary Incontinence

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators would like to compare the effectiveness of acupuncture and drug therapy on blood pressure.

The investigators chose acupuncture point according the Traditional Chinese Medicine theory, besides, each patient was using 1-3 antihypertensive drug of a heterogeneous pharmacological group ranging from angiotensin-converting enzyme inhibitor (ACE inhibitor), diuretics, and beta blockers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

drug use

routine drug use, each patient was using 1-3 antihypertensive drug of a heterogeneous pharmacological group ranging from ACE inhibitors, diuretics, and beta blockers

Group Type NO_INTERVENTION

No interventions assigned to this group

drug combine acupuncture

routine drug use combine acupuncture twice a week for 3 months

Group Type EXPERIMENTAL

acupuncture

Intervention Type OTHER

antihypertension drug, acupuncture twice a week for 3 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

acupuncture

antihypertension drug, acupuncture twice a week for 3 months

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

drug

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. patient with isolated blood pressure diagnosis by physicians and BP \>140/\<90 mmHg
2. patient took the drug to control blood pressure for more than one year
3. age\>65 years old
4. Willing to participate in this study

Exclusion Criteria

1. Suspected acute stroke
2. chest pain or dyspnea
3. ingestion of short-acting antihypertensive medication within 2 h prior to the beginning of the study
4. body temperature \>37.5∘C(99.5∘F)

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No